Search Results - "Emde-Rajaratnam M"

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Authors: Hose D Ray S Rößler S et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2024 Dec 18; Vol. 17 (1), pp. 128. Date of Electronic Publication: 2024 Dec 18.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.

Authors: Emde-Rajaratnam M Beck S Benes V et al.

Source: Frontiers in immunology [Front Immunol] 2023 Nov 15; Vol. 14, pp. 1286700. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).

Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma—Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries

Authors: Seckinger, Anja Salwender, Hans Martin, Hans et al.

Source: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6431. 19p.

Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy.

Authors: Behsen, Alenka Djarmila Holien, Toril Micci, Francesca et al.

Source: Scientific Reports. 11/20/2024, Vol. 14 Issue 1, p1-8. 8p.

Clinical bioinformatics desiderata for molecular tumor boards.

Authors: Pallocca, Matteo Betti, Martina Baldinelli, Sara et al.

Source: Briefings in Bioinformatics. Sep2024, Vol. 25 Issue 5, p1-9. 9p.

Expression of WNT Family Genes in Mesenchymal Stromal Cells of the Hematopoietic Niche in Patients with Different Responses to Multiple Myeloma Treatment.

Authors: Belik, Liubov A. Enukashvily, Natella I. Semenova, Natalia Y. et al.

Source: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 13, p6236. 22p.

Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress), 01.-04. Oktober 2021: Abstracts.

Source: Oncology Research & Treatment. 2021Supplement, Vol. 44 Issue 1, p1-335. 335p.

Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Authors: Hose D Ray S Rößler S et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2025 Jan 24; Vol. 18 (1), pp. 11. Date of Electronic Publication: 2025 Jan 24.

Publication Type: Published Erratum

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE; PubMed not MEDLINE

CD79B in myelodysplastic syndromes and acute myeloid leukemia: an integrative computational and in vitro study.

Authors: Kong X Wei Y Zhang S et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2026 Jan 16; Vol. 12, pp. 1650035. Date of Electronic Publication: 2026 Jan 16 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response.

Authors: Zhang L Wirth M Patra U et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2023 Sep 11; Vol. 15 (9), pp. e16431. Date of Electronic Publication: 2023 Jul 24.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE